Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Michael Saylor projects Bitcoin could reach $7 million at BTC Prague 2026 keynote.

Market News
15 Jun 2026
Crypto Briefing
View Source
Bullish
pluang ai news

At BTC Prague 2026, Michael Saylor, executive chairman of Strategy, declared "Bitcoin has already won" and projected a potential peak price of $7 million per Bitcoin. He outlined a corporate treasury strategy for holding Bitcoin, emphasizing its role as digital capital distinct from traditional assets. Strategy holds over 700,000 BTC, making it one of the largest corporate holders, but this concentration carries risks if Bitcoin faces a prolonged downturn. The event drew over 10,000 attendees and sparked discussions on Bitcoin valuation methods like mNAV, highlighting evolving corporate approaches to Bitcoin treasury management.

More News

Class action filed against Nano-X for alleged securities fraud, investors urged to join by Aug 11, 2026.

Class action filed against Nano-X for alleged securities fraud, investors urged to join by Aug 11, 2026.

A class action lawsuit has been filed against Nano-X Imaging Ltd. and some of its officers, accusing them of making false and misleading statements about the company's operations and prospects between March 31, 2025, and April 17, 2026. The lawsuit c...

Market News
Bearish
45 minutes ago
Osteoarthritis market to grow 3% CAGR through 2036, fueled by new therapies and rising disease cases

Osteoarthritis market to grow 3% CAGR through 2036, fueled by new therapies and rising disease cases

The osteoarthritis market is projected to grow at a moderate CAGR of 3% from 2026 to 2036, driven by an aging population and increasing disease prevalence. Emerging therapies like LEVI-04, ZILOSUL, TissueGene-C, and others are expected to enter the m...

Market News
Bullish
45 minutes ago
Rhythm Pharma shares rise after positive 6-month data on obesity drug setmelanotide in Prader-Willi syndrome patients.

Rhythm Pharma shares rise after positive 6-month data on obesity drug setmelanotide in Prader-Willi syndrome patients.

Rhythm Pharmaceuticals reported encouraging six-month Phase 2 trial results for setmelanotide in patients with Prader-Willi syndrome, showing improvements in BMI, body composition, hyperphagia, and behavior. The study involved 18 patients aged 6 to 2...

Company Fundamentals
Bullish
54 minutes ago
FDA approves AstraZeneca's Truqap for targeted prostate cancer treatment; Ultomiris gets Priority Review for kidney disease.

FDA approves AstraZeneca's Truqap for targeted prostate cancer treatment; Ultomiris gets Priority Review for kidney disease.

AstraZeneca received FDA approval for Truqap (capivasertib) combined with abiraterone and prednisone to treat PTEN-deficient metastatic prostate cancer, marking the first targeted therapy for this group. The approval was based on Phase III trial data...

Market News
Bullish
54 minutes ago
TripAdvisor sells TheFork to American Express for $700M, boosting capital return plans.

TripAdvisor sells TheFork to American Express for $700M, boosting capital return plans.

TripAdvisor has agreed to sell its European restaurant reservation platform, TheFork, to American Express for $700 million in cash. TheFork generated $232 million in revenue and $28 million in adjusted EBITDA in the past year. This sale supports Trip...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App